These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 36178962)
1. Intermittent preventive treatment with Sulphadoxine-Pyrimethamine (IPTp-SP) is associated with protection against sub-microscopic P. falciparum infection in pregnant women during the low transmission dry season in southwestern Cameroon: A Semi - longitudinal study. Apinjoh TO; Ntui VN; Chi HF; Moyeh MN; Toussi CT; Mayaba JM; Tangi LN; Kwi PN; Anchang-Kimbi JK; Dionne-Odom J; Tita ATN; Achidi EA; Amambua-Ngwa A; Titanji VPK PLoS One; 2022; 17(9):e0275370. PubMed ID: 36178962 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model. Walker PG; Floyd J; Ter Kuile F; Cairns M PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259 [TBL] [Abstract][Full Text] [Related]
4. Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon. Bouyou-Akotet MK; Mawili-Mboumba DP; Kendjo E; Moutandou Chiesa S; Tshibola Mbuyi ML; Tsoumbou-Bakana G; Zong J; Ambounda N; Kombila M Trans R Soc Trop Med Hyg; 2016 Jun; 110(6):333-42. PubMed ID: 27268713 [TBL] [Abstract][Full Text] [Related]
5. Uptake of intermittent preventive treatment of malaria in pregnancy and risk factors for maternal anaemia and low birthweight among HIV-negative mothers in Dschang, West region of Cameroon: a cross sectional study. Kamga SLS; Ali IM; Ngangnang GR; Ulucesme MC; Keptcheu LTD; Keming EM; Tchuenkam VK; Foyet JV; Aktas M; Noubom M; Payne VK Malar J; 2024 Jan; 23(1):6. PubMed ID: 38178125 [TBL] [Abstract][Full Text] [Related]
6. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Verhoeff FH; Brabin BJ; Chimsuku L; Kazembe P; Russell WB; Broadhead RL Ann Trop Med Parasitol; 1998 Mar; 92(2):141-50. PubMed ID: 9625909 [TBL] [Abstract][Full Text] [Related]
7. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria. Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228 [TBL] [Abstract][Full Text] [Related]
8. Sulfadoxine-pyrimethamine parasitological efficacy against Plasmodium falciparum among pregnant women and molecular markers of resistance in Zambia: an observational cohort study. Chaponda EB; Mharakurwa S; Michelo C; Bruce J; Chandramoha D; Matthew Chico R Malar J; 2021 Jan; 20(1):61. PubMed ID: 33482823 [TBL] [Abstract][Full Text] [Related]
9. Sub-microscopic Plasmodium falciparum parasitaemia, dihydropteroate synthase (dhps) resistance mutations to sulfadoxine-pyrimethamine, transmission intensity and risk of malaria infection in pregnancy in Mount Cameroon Region. Mbacham HF; Mosume DM; Apinjoh TO; Ntui VN; Moyeh MN; Kalaji LN; Wepnje GB; Ghogomu SM; Dionne JA; Tita ATN; Achidi EA; Anchang-Kimbi JK Malar J; 2023 Mar; 22(1):73. PubMed ID: 36864514 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia. Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR Malar J; 2015 Feb; 14():69. PubMed ID: 25890159 [TBL] [Abstract][Full Text] [Related]
11. Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study. Agyeman YN; Newton S; Annor RB; Owusu-Dabo E PLoS One; 2021; 16(4):e0250350. PubMed ID: 33878140 [TBL] [Abstract][Full Text] [Related]
12. Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon. Anchang-Kimbi JK; Kalaji LN; Mbacham HF; Wepnje GB; Apinjoh TO; Ngole Sumbele IU; Dionne-Odom J; Tita ATN; Achidi EA Malar J; 2020 Mar; 19(1):100. PubMed ID: 32122339 [TBL] [Abstract][Full Text] [Related]
13. Malaria Infection Is Common and Associated With Perinatal Mortality and Preterm Delivery Despite Widespread Use of Chemoprevention in Mali: An Observational Study 2010 to 2014. Mahamar A; Andemel N; Swihart B; Sidibe Y; Gaoussou S; Barry A; Traore M; Attaher O; Dembele AB; Diarra BS; Keita S; Dicko A; Duffy PE; Fried M Clin Infect Dis; 2021 Oct; 73(8):1355-1361. PubMed ID: 33846719 [TBL] [Abstract][Full Text] [Related]
14. Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Benin. Jafari-Guemouri S; Dhiab J; Massougbodji A; Deloron P; Tuikue NN Malar J; 2018 Oct; 17(1):356. PubMed ID: 30305101 [TBL] [Abstract][Full Text] [Related]
15. Suboptimal Intermittent Preventive Treatment in Pregnancy (IPTp) is Associated With an Increased Risk of Submicroscopic Plasmodium falciparum Infection in Pregnant Women: A Prospective Cohort Study in Benin. Hounkonnou CPA; Ndam NT; Fievet N; Accrombessi M; Yovo E; Mama A; Sossou D; Vianou B; Massougbodji A; Briand V; Cot M; Cottrell G Clin Infect Dis; 2021 Dec; 73(11):e3759-e3767. PubMed ID: 32901806 [TBL] [Abstract][Full Text] [Related]
16. Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis. van Eijk AM; Larsen DA; Kayentao K; Koshy G; Slaughter DEC; Roper C; Okell LC; Desai M; Gutman J; Khairallah C; Rogerson SJ; Hopkins Sibley C; Meshnick SR; Taylor SM; Ter Kuile FO Lancet Infect Dis; 2019 May; 19(5):546-556. PubMed ID: 30922818 [TBL] [Abstract][Full Text] [Related]
17. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania. Mikomangwa WP; Minzi O; Mutagonda R; Baraka V; Mlugu EM; Aklillu E; Kamuhabwa AAR Malar J; 2020 Apr; 19(1):160. PubMed ID: 32306955 [TBL] [Abstract][Full Text] [Related]
18. Microscopic and submicroscopic Plasmodium falciparum infection, maternal anaemia and adverse pregnancy outcomes in Papua New Guinea: a cohort study. Unger HW; Rosanas-Urgell A; Robinson LJ; Ome-Kaius M; Jally S; Umbers AJ; Pomat W; Mueller I; Kattenberg E; Rogerson SJ Malar J; 2019 Sep; 18(1):302. PubMed ID: 31477117 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial. Kimani J; Phiri K; Kamiza S; Duparc S; Ayoub A; Rojo R; Robbins J; Orrico R; Vandenbroucke P PLoS One; 2016; 11(6):e0157045. PubMed ID: 27326859 [TBL] [Abstract][Full Text] [Related]
20. Malaria risk factors in women on intermittent preventive treatment at delivery and their effects on pregnancy outcome in Sanaga-Maritime, Cameroon. Tonga C; Kimbi HK; Anchang-Kimbi JK; Nyabeyeu HN; Bissemou ZB; Lehman LG PLoS One; 2013; 8(6):e65876. PubMed ID: 23762446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]